Last Updated: June 28, 2026

CHLORPHENIRAMINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Chlorpheniramine patents expire, and when can generic versions of Chlorpheniramine launch?

Chlorpheniramine is a drug marketed by Aurolife Pharma Llc, Bel Mar, Elkins Sinn, Watson Labs, Pharm Assoc, Avanthi Inc, Anabolic, Bell Pharma, Impax Labs, Ivax Sub Teva Pharms, Kv Pharm, Lederle, Newtron Pharms, Panray, Pharmavite, Pharmeral, Pioneer Pharms, Purepac Pharm, Pvt Form, Roxane, Sun Pharm Industries, Vitarine, and West Ward. and is included in thirty NDAs.

The generic ingredient in CHLORPHENIRAMINE is chlorpheniramine maleate. There are twenty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Chlorpheniramine

A generic version of CHLORPHENIRAMINE was approved as chlorpheniramine maleate by AVANTHI INC on May 13th, 2009.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for CHLORPHENIRAMINE?
  • What are the global sales for CHLORPHENIRAMINE?
  • What is Average Wholesale Price for CHLORPHENIRAMINE?
Summary for CHLORPHENIRAMINE

US Patents and Regulatory Information for CHLORPHENIRAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 080791-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Watson Labs CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 085139-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Aurolife Pharma Llc CHLORPHENIRAMINE MALEATE chlorpheniramine maleate CAPSULE, EXTENDED RELEASE;ORAL 070797-001 Aug 12, 1988 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Panray CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 083243-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Roxane CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 080626-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Pharm Assoc CHLORPHENIRAMINE MALEATE chlorpheniramine maleate SYRUP;ORAL 087520-001 Feb 10, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Watson Labs CHLORPHENIRAMINE MALEATE chlorpheniramine maleate INJECTABLE;INJECTION 083593-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
DrugChatter Q&A for CHLORPHENIRAMINE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.